A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors
Clinical trial NCT06241898 · RECRUITING
Trial details
- NCT number
- NCT06241898
- Sponsor
- Bliss Biopharmaceutical (Hangzhou) Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2026-06-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.